NEDD4 and colorectal cancer: In human malignancies such as gastric, colorectal cancer, NSCLC (non-small-cell lung carcinoma), hepatocellular carcinoma, and others, NEDD4 is commonly overexpressed and is an important factor in medication resistance during cancer treatment.